$AMRX

$21.02 +$0.64 (3.14%) Close

$AMRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 319.4M shares outstanding

Who owns AMRX?

By type of holder

Institutions 51.2% Insiders 0.0% Everyone else 48.8%

Concentration Top 10 holders own 67.7%

Tushar Patel 19.2% · Chintu Patel 10.2%

Institutional ownership

51.2%

+0.9 pts vs last qtr

Institutional holders

310

-7 vs last qtr

Net shares bought

+2.7M

by institutions in Q2 2026

New / sold out

48 / 55

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +2.0M
Vanguard Portfolio Management LLC +812.8K

Biggest sellers in Q2 2026

D. E. Shaw & Co., Inc. −945.9K
Rubric Capital Management LP −868.9K

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.61M

3 notices from 3 people

Shares covered

216.7K

0.07% of the company

Arranged in advance

17%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Nikita Shah Officer $1.57M
Nark Ted C Director $591K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+113.9%

+20.94% a year

Each share's claim on the business

−53.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $147M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years60% 3–5 years20% 1–3 years12% Under 1 year8%

Quarterly turnover

8.4%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting AMRX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	26.6M	8.32%	+2.0M (+8.3%)	≤2021	0.0%
Shares held by quarter Peak holding26.6M (Q2'26) Change over 8 quarters+14.2M Share of the company8.320% BlackRock, Inc.'s full portfolio →
TG TPG GP A, LLC	12.3M	3.86%	Unchanged	2021	4.3%
Shares held by quarter Peak holding12.3M (Q3'24) Change over 8 quarters0 Share of the company3.860% TPG GP A, LLC's full portfolio →

BlackRock, Inc.

26.6M

% of company

8.32%

Change vs last qtr

+2.0M (+8.3%)

Held since

≤2021

TPG GP A, LLC

12.3M

% of company

3.86%

Change vs last qtr

Unchanged

Held since

2021

28 more super investors behind a free account

See every manager holding Amneal Pharmaceuticals, Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting AMRX on Form N-PORT; together they hold 23.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$180M	10.4M	3.25%	0.16%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$96.2M	5.6M	1.74%	0.00%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$180M

% of company

3.25%

% of the fund

0.16%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$96.2M

% of company

1.74%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Amneal Pharmaceuticals, Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TP Tushar Patel 5%+ holder 13D · 17.6%	61.3M	19.21%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company19.210% Disclosed stake13D · 17.6% View the 13D/G filing →
CP Chintu Patel 5%+ holder 13D · 9.4%	32.6M	10.20%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.200% Disclosed stake13D · 9.4% View the 13D/G filing →

Tushar Patel

5%+ holder13D · 17.6%

61.3M

% of company

19.21%

Change vs last qtr

—

Held since

—

Chintu Patel

5%+ holder13D · 9.4%

32.6M

% of company

10.20%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Amneal Pharmaceuticals, Inc.

Comments